Fund Holdings — Tri Locum Partners LP

Total Portfolio Value:
$395.50M
Total Bought:
$232.06M
Total Sold:
$116.30M
Net Transaction:
+$115.76M
Notable People:
Tri Locum Partners Gp Llc
Securities
▲▼
SharesValue
Q1 2024
▲▼
Q2 2024
▲▼
Change
▲▼
Q1 2024
▲▼
Q2 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Teva Pharmaceutical Industries LimitedADS(TEVA)2,216,1882,550,307+334,119$31.27M$41.44M10.48%+$10.17M
argenx SEADR(ARGX)27,98174,558+46,577$11.02M$32.06M8.11%+$21.05M
Ascendis Pharma A/SADR(ASND)112,670227,762+115,092$17.03M$31.06M7.85%+$14.03M
Amgen Inc.(AMGN)082,271+82,271$0$25.71M6.50%+$25.71M
Natera, Inc.(NTRA)190,114230,585+40,471$17.39M$24.97M6.31%+$7.58M
Axsome Therapeutics, Inc.(AXSM)102,711306,513+203,802$8.20M$24.67M6.24%+$16.48M
Insmed Incorporated(INSM)0316,501+316,501$0$21.21M5.36%+$21.21M
Merus N V286,322335,514+49,192$12.89M$19.85M5.02%+$6.96M
Regeneron Pharmaceuticals, Inc.(REGN)8,56717,516+8,949$8.25M$18.41M4.65%+$10.16M
Madrigal Pharmaceuticals, Inc.(MDGL)53,35565,352+11,997$14.25M$18.31M4.63%+$4.06M
Inspire Medical Systems, Inc.(INSP)23,566133,276+109,710$5.06M$17.84M4.51%+$12.77M
Avadel Pharmaceuticals PlcADR1,189,5111,189,518+7$20.09M$16.72M4.23%-$3.37M
Pfizer Inc.(PFE)0596,919+596,919$0$16.70M4.22%+$16.70M
United Therapeutics Corporation(UTHR)050,100+50,100$0$15.96M4.04%+$15.96M
Legend Biotech CorporationADS(LEGN)283,773356,532+72,759$15.92M$15.79M3.99%-$126.0K
Alnylam Pharmaceuticals, Inc.(ALNY)045,000+45,000$0$10.94M2.76%+$10.94M
Stevanato Group S P A
ORD SHS
0565,422+565,422$0$10.37M2.62%+$10.37M
Novo Nordisk A/SADR(NVO)063,811+63,811$0$9.11M2.30%+$9.11M
Vaxcyte, Inc.(PCVX)0113,344+113,344$0$8.56M2.16%+$8.56M
Xenon Pharmaceuticals Inc.(XENE)207,465101,959-105,506$8.93M$3.98M1.01%-$4.96M
Ocular Therapeutix, Inc.(OCUL)0514,642+514,642$0$3.52M0.89%+$3.52M
Praxis Precision Medicines, Inc.(PRAX)106,49475,319-31,175$6.50M$3.12M0.79%-$3.38M
Mind Medicine Mindmed Inc379,596382,055+2,459$3.57M$2.75M0.70%-$813.6K
Korro Bio, Inc.(KRRO)071,428+71,428$0$2.42M0.61%+$2.42M
Femasys Inc30,60630,6060$47.4K$34.9K0.01%-$12.5K
Alpine Immune Sciences Inc120,6870-120,687$4.78M$0—-$4.78M
Arcturus Therapeutics Holdings Inc.(ARCT)138,9270-138,927$4.69M$0—-$4.69M
Arcutis Biotherapeutics, Inc.(ARQT)449,6940-449,694$4.46M$0—-$4.46M
Astria Therapeutics Inc369,5490-369,549$5.20M$0—-$5.20M
Baxter Intl Inc317,5660-317,566$13.57M$0—-$13.57M
Endeavour Silver Corp.(EXK)90,0000-90,000$6.22M$0—-$6.22M
Lyra Therapeutics Inc978,7930-978,793$6.09M$0—-$6.09M
Merck & Co., Inc.(MRK)119,2000-119,200$15.73M$0—-$15.73M
Perspective Therapeutics, Inc.(CATX)780,3030-780,303$928.6K$0—-$928.6K
Silk Rd Med Inc1,083,6050-1,083,605$19.85M$0—-$19.85M
Tandem Diabetes Care, Inc.(TNDM)326,5060-326,506$11.56M$0—-$11.56M
Vertex Pharmaceuticals Incorporated(VRTX)35,5980-35,598$14.88M$0—-$14.88M
Page 1 of 1
Tri Locum Partners LP — 13F Holdings — Q2 2024 | TickerTrail